NEW YORK (GenomeWeb) – Grifols today announced the Procleix HEV assay for detection of hepatitis E has received CE marking.

Developed in collaboration with Hologic, the test uses nucleic acid amplification technology for the fully automated detection of hepatitis E virus RNA in blood, tissue, and organ donors. The Procleix HEV assay detects all four genotypes of the virus in plasma and serum specimens and will be sold for use on the Procleix Panther system in parts of Europe and other geographies that recognize CE marking.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.